News

Phison Showcases Cutting-Edge Gen5 Storage Solutions at CES

Phison Showcases Cutting-Edge Gen5 Storage Solutions at CES

Phison Electronics Excites with Gen5 Offerings at CES 2025

Phison Electronics, an innovative leader in NAND Flash technology, recently unveiled an impressive showcase of advancements at the bustling Consumer Electronics Show (CES) 2025. With a commitment to enhancing high-performance storage solutions, their product lineup features groundbreaking technologies designed to meet the ever-growing demands of modern computing.

Introducing the PS5028-E28 PCIe Gen5 SSD Controller

At the forefront of Phison’s showcase is the PS5028-E28, a PCIe Gen5 SSD controller that stands out as a remarkable engineering achievement. Utilizing TSMC’s cutting-edge 6nm process node, this controller achieves unbeatable sequential read and write speeds of up to 14.5GB/s. For those in pursuit of high-performance storage solutions, the E28 is a prime contender, showcasing Phison’s relentless pursuit of excellence.

Performance Innovation with the PS5031-E31T Controller

Next in line is the PS5031-E31T PCIe Gen5 SSD controller, which holds the title of the world’s first DRAM-less controller to achieve10GB/s performance. This impressive feat makes it a fantastic choice for mainstream users, proving that high-quality storage doesn’t need to come with a high price tag. With this innovation, Phison offers a viable solution that balances performance with cost-effectiveness.

Revolutionizing Portable Solutions: PS2251-21 U21 USB4 SoC

Among Phison’s revolutionary products is the PS2251-21 U21 USB4 SoC—heralded as the first native USB4 SoC globally. This technology enables up to 4GB/s sequential read and write speeds, catering to the needs of low-power and high-performance applications in portable devices. Its compact form factor ensures versatility without compromising on power.

Pascari D205V Enterprise SSD: A Game Changer in Data Centers

For enterprise applications, Phison presents the Pascari D205V Enterprise SSD, touted as the highest-capacity PCIe Gen5 SSD with a staggering 122.88TB of storage. With read speeds reaching up to 14,600 MB/s and write speeds of 3,200 MB/s, this innovative solution is designed for data center scalability and efficiency, setting new standards for enterprise-level storage.

Meeting Modern Demands with Phison’s Technology

Phison’s latest advancements underline an essential commitment to addressing challenges in the storage space, including durability, capacity, and sustainability. As workloads from gaming, content creation, and AI training continue to rise, Phison’s innovations are crucial in providing reliable and rapid storage solutions that empower users to achieve more.

Partnering for Performance: Phison and Micron Collaboration

Phison’s controllers are making headway in notable products like the Crucial P510 SSD. This newly announced consumer SSD, powered by the E31T controller, delivers impressive Gen5 performance at up to 11,000/9,500 MB/s. Designed for energizing the computing experience of gamers and creatives alike, this drive exemplifies the advantages brought by partnerships that fuse advanced technology with practical consumer needs.

About Phison Electronics

Phison Electronics Corp. (TPEX:8299) stands as a premier entity in NAND Flash controller IC and storage solutions. Offering a spectrum of services including controller design and system integration, Phison caters to various applications across SSD interfaces, positioning itself as a key player in consumer, industrial, and enterprise markets. Phison’s active involvement in multiple industry associations solidifies its role as a leader in storage technology, making substantial contributions to numerous industry standards.

Frequently Asked Questions

What is the PS5028-E28 PCIe Gen5 SSD Controller?

The PS5028-E28 is Phison's flagship controller that achieves exceptional read and write speeds of up to 14.5GB/s, designed for high-performance storage applications.

What makes the PS5031-E31T unique?

The PS5031-E31T is the world's first DRAM-less PCIe Gen5 SSD controller delivering over 10GB/s performance, making it cost-effective for mainstream users.

What are the key highlights of the Pascari D205V Enterprise SSD?

This enterprise SSD provides 122.88TB of high-capacity storage with remarkable sequential speeds, tailored for data center efficiency and scalability.

How does Phison address modern storage challenges?

Phison engineers solutions that focus on durability, capacity, and sustainability while ensuring high speed and efficiency in storage technologies.

What recent partnerships has Phison formed?

Phison has strengthened its collaboration with Micron to develop desirable products like the Crucial P510 SSD, utilizing advanced technology for outstanding performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 3

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 6

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading